Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122024755 | 12202475 | 5 | F | 20160509 | 20160624 | 20160322 | 20160712 | EXP | GB-PFM-GB-2015-5098 | PIERRE FABRE MEDICAMENT | 53.00 | YR | F | Y | 0.00000 | 20160712 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122024755 | 12202475 | 1 | PS | VINORELBINE INN | VINORELBINE TARTRATE | 1 | Oral | UNK MG, UNK | U | U | 20388 | CAPSULE, SOFT | |||||||
| 122024755 | 12202475 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | U | U | 0 | |||||||||
| 122024755 | 12202475 | 3 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | U | U | 0 | |||||||||
| 122024755 | 12202475 | 4 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Subcutaneous | 600 MG, UNK | U | 0 | 600 | MG | |||||||
| 122024755 | 12202475 | 5 | SS | Chlorhexidine | CHLORHEXIDINE | 1 | Unknown | UNK | U | U | 0 | IRRIGATION SOLUTION | |||||||
| 122024755 | 12202475 | 6 | C | Granisetron | GRANISETRON | 1 | Unknown | U | 0 | TRANSDERMAL PATCH | |||||||||
| 122024755 | 12202475 | 7 | C | NEULASTA | PEGFILGRASTIM | 1 | Unknown | U | U | 0 | |||||||||
| 122024755 | 12202475 | 8 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122024755 | 12202475 | 1 | Product used for unknown indication |
| 122024755 | 12202475 | 2 | Product used for unknown indication |
| 122024755 | 12202475 | 3 | Product used for unknown indication |
| 122024755 | 12202475 | 4 | Product used for unknown indication |
| 122024755 | 12202475 | 5 | Product used for unknown indication |
| 122024755 | 12202475 | 6 | Product used for unknown indication |
| 122024755 | 12202475 | 7 | Product used for unknown indication |
| 122024755 | 12202475 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122024755 | 12202475 | HO |
| 122024755 | 12202475 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122024755 | 12202475 | Allergy to chemicals | |
| 122024755 | 12202475 | Anaemia | |
| 122024755 | 12202475 | Blood creatinine increased | |
| 122024755 | 12202475 | Constipation | |
| 122024755 | 12202475 | Cough | |
| 122024755 | 12202475 | Diarrhoea | |
| 122024755 | 12202475 | Drug hypersensitivity | |
| 122024755 | 12202475 | Dysgeusia | |
| 122024755 | 12202475 | Dysphonia | |
| 122024755 | 12202475 | Dyspnoea exertional | |
| 122024755 | 12202475 | Fatigue | |
| 122024755 | 12202475 | Hypoaesthesia | |
| 122024755 | 12202475 | Limb discomfort | |
| 122024755 | 12202475 | Lymphoedema | |
| 122024755 | 12202475 | Metastases to skin | |
| 122024755 | 12202475 | Movement disorder | |
| 122024755 | 12202475 | Musculoskeletal disorder | |
| 122024755 | 12202475 | Nausea | |
| 122024755 | 12202475 | Neuralgia | |
| 122024755 | 12202475 | Neuropathy peripheral | |
| 122024755 | 12202475 | Oedema | |
| 122024755 | 12202475 | Pain in extremity | |
| 122024755 | 12202475 | Paraesthesia | |
| 122024755 | 12202475 | Pyrexia | |
| 122024755 | 12202475 | Rhinorrhoea | |
| 122024755 | 12202475 | Sensory loss | |
| 122024755 | 12202475 | Vomiting | |
| 122024755 | 12202475 | Wound | |
| 122024755 | 12202475 | Wound haemorrhage | |
| 122024755 | 12202475 | Wound secretion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122024755 | 12202475 | 4 | 2012 | 0 |